MedPath

Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI

Not Applicable
Conditions
Percutaneous Coronary Intervention
Acute Myocardial Infarction
Interventions
Device: Deferred stent implantation
Device: Immediate stent implantation
Registration Number
NCT03282773
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

This study will compare clinical outcomes of immediate stent implantation with deferred stent implantation(4-10days after primary angiography) for patients presented with acute myocardial infarction due to left main coronary artery occlusion.

Detailed Description

Primary percutaneous coronary intervention for patients presented with acute myocardial infarction caused by left main coronary artery occlusion is associated with significantly higher mortality and risks of major cardiac adverse events. Deferred stent implantation may improve prognosis of primary PCI through reducing distal embolization and no-reflow phenomenon. There is no randomized clinical trial focuses on the effect and outcome of deferred stent implantation on primary PCI for left main coronary artery occlusion in contrast with conventional strategy.

This prospective, multicenter, randomized trial is aimed to compare immediate stenting with deferred stenting for LM-AMI with 30 centers in China involved. We hope to determine whether deferred stenting is superior to conventional strategy for primary PCI of AMI caused by left main coronary artery occlusion in improving long-term clinical outcomes and cardiac function.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
480
Inclusion Criteria
  • Clinical diagnosis of acute myocardial infarction occured within 12 hours
  • Left main coronary artery occlusion confirmed by angiography
  • Left main coronary artery occlusion (TIMI flow 0,1 or 2) confirmed by primary angiography, TIMI flow grade 3 achieved after pretreatment of thrombus aspiration or balloon dilatation
Exclusion Criteria
  • Life expectancy less than 1 years
  • Cardiogenic shock
  • Chronic kidney disease, stage 4 by KDOQI(GFR<30ml/min)
  • Contraindications to aspirin or other anti-platelet drugs
  • Allergy to contrast agent, rapamycin or paclitaxel
  • Patients who are included in other ongoing trials
  • Pregnant female

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Deferred stent implantationDeferred stent implantationDrug-eluting stents are implanted 4-10 days after primary angiography and restoration of blood flow in left main coroanry artery in a secondary PCI
Immediate stent implantationImmediate stent implantationDrug-eluting stents are implanted immediately after primary angiography and restoration of blood flow in left main coroanry artery
Primary Outcome Measures
NameTimeMethod
Composite of cardiac death and recurrent myocardial infarction30 days after primary angiography

Recorded in follow-up

Secondary Outcome Measures
NameTimeMethod
All cause death, cardiac death, recurrent myocardial infarction, target vessel revascularization30 days after primary angiography

Recorded in follow-up

Residual stenosis of left main coronary arteryImmediately after stent implantation and 12 months after primary angiography

Measured through angiography

Left ventricular ejection fraction30 days and 12 months after primary angiography

Measured through echocardiogram

Trial Locations

Locations (1)

Zhongshan Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath